Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Perspective on Newly Emerging Proteolysis-Targeting Strategies in Antimicrobial Drug Discovery. | Antibiotics (Basel) | 2022 | 36551374 | PubTator, text mining | PubMed |
| Regulation of programmed cell death by Brd4. | Cell Death Dis | 2022 | 36539410 | PubTator, text mining | PubMed |
| An overview of PROTACs: a promising drug discovery paradigm. | Mol Biomed | 2022 | 36536188 | PubTator, text mining | PubMed |
| In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors. | Blood Cancer J | 2022 | 36535935 | PubTator, text mining | PubMed |
| Cellular functions and molecular mechanisms of ubiquitination in osteosarcoma. | Front Oncol | 2022 | 36530999 | PubTator, text mining | PubMed |
| Hypoxia deactivates epigenetic feedbacks via enzyme-derived clicking proteolysis-targeting chimeras. | Sci Adv | 2022 | 36516252 | PubTator, text mining | PubMed |
| Diffuse Large B-Cell Lymphoma (DLBCL): Early Patient Management and Emerging Treatment Options. | Onco Targets Ther | 2022 | 36510607 | PubTator, text mining | PubMed |
| Small-molecule PROTAC mediates targeted protein degradation to treat STAT3-dependent epithelial cancer. | JCI Insight | 2022 | 36509291 | PubTator, text mining | PubMed |
| Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAFV600E Protein. | Molecules | 2022 | 36500607 | PubTator, text mining | PubMed |
| Current Challenges in Small Molecule Proximity-Inducing Compound Development for Targeted Protein Degradation Using the Ubiquitin Proteasomal System. | Molecules | 2022 | 36500212 | PubTator, text mining | PubMed |
| Targeted Protein Degradation: Clinical Advances in the Field of Oncology. | Int J Mol Sci | 2022 | 36499765 | PubTator, text mining | PubMed |
| Progress in Anticancer Drug Development Targeting Ubiquitination-Related Factors. | Int J Mol Sci | 2022 | 36499442 | PubTator, text mining | PubMed |
| Natural Killer Cells in Chronic Lymphocytic Leukemia: Functional Impairment and Therapeutic Potential. | Cancers (Basel) | 2022 | 36497266 | PubTator, text mining | PubMed |
| Immunomodulatory Agents for Multiple Myeloma. | Cancers (Basel) | 2022 | 36497241 | PubTator, text mining | PubMed |
| Machine Learning Modeling of Protein-intrinsic Features Predicts Tractability of Targeted Protein Degradation. | Genomics Proteomics Bioinformatics | 2022 | 36494034 | PubTator, text mining | PubMed |
| Beyond the cell: novel noncellular immunotherapy approaches to multiple myeloma. | Hematology Am Soc Hematol Educ Program | 2022 | 36485098 | PubTator, text mining | PubMed |
| Lupus Nephritis: Current Perspectives and Moving Forward. | J Inflamm Res | 2022 | 36483271 | PubTator, text mining | PubMed |
| Implementation of Whole-Genome and Transcriptome Sequencing Into Clinical Cancer Care. | JCO Precis Oncol | 2022 | 36480778 | PubTator, text mining | PubMed |
| Solid-Phase Synthesis of Cereblon-Recruiting Selective Histone Deacetylase 6 Degraders (HDAC6 PROTACs) with Antileukemic Activity. | J Med Chem | 2022 | 36473103 | PubTator, text mining | PubMed |
| Lower-risk myelodysplastic syndromes: Current treatment options for anemia. | EJHaem | 2022 | 36467818 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=48